Stephanie J. Wang

Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance

Miles A. Miller, Madeleine J. Oudin, Ryan J. Sullivan et al. · Cancer Discovery · 2016 · 166 citations · Full text

Therapeutically reprogrammed nutrient signalling enhances nanoparticulate albumin bound drug uptake and efficacy in KRAS-mutant cancer

Ran Li, Thomas S.C. Ng, Stephanie J. Wang et al. · Nature Nanotechnology · 2021 · 113 citations · Full text

Tumor Biology, Nanomedicine, Drug Targeting +10

Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors

Mark Merchant, John G. Moffat, Gabriele Schaefer et al. · PLoS ONE · 2017 · 90 citations · Full text

Erk Inhibition, Cancer Biology, Braf Mutant Models +16

Simultaneous concentration and detection of biomarkers on paper

Ricky Y. T. Chiu, Erik Jue, Allison T. Yip et al. · Lab on a Chip · 2014 · 52 citations

Efficient blockade of locally reciprocated tumor-macrophage signaling using a TAM-avid nanotherapy

Stephanie J. Wang, Ran Li, Thomas S.C. Ng et al. · Science Advances · 2020 · 32 citations · Full text

Tam-avid Nanotherapy, Nanotherapeutics, Mapk-driven Disease +21